Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,434,875 papers from all fields of science
Search
Sign In
Create Free Account
ECOG performance status
Known as:
ECOG Score
, ECOG1-Performance Status
, ECOG101
Expand
A performance status scale designed to assess disease progression and its affect on the daily living abilities of the patient.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC Questionnaire ECOG Test Code Terminology
Clinical Data Interchange Standards Consortium Terminology
Zubrod Performance Status
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Non-Hodgkin Lenfomada Tromboz riski ve sıklığının retrospektif analizi
Vagif Valiyev
2019
Corpus ID: 212824687
Valiyev V. Non-Hodgkin Lenfomada Tromboz riski ve sikligi retrospektif analizi. Hacettepe Universitesi Tip Fakultesi Ic…
Expand
2017
2017
ECOG or Karnofsky Performance Status to Assess Functionality in Glioblastoma Patients Among Different Observers
C. Panciroli
,
A. Estival
,
+6 authors
C. Balañà
2017
Corpus ID: 67757997
Purpose: Glioblastoma (GB) patients usually have symptoms that affect their functional status, and medical staff, as well as the…
Expand
2015
2015
Применение эверолимуса у больных метастатическим раком почки, ранее получавших бевацизумаб: проспективное многоцентровое исследование CRAD001LRU02T
И. В. Тимофеев
,
А. В. Снеговой
,
+4 authors
Л. В. Манзюк
2015
Corpus ID: 73763167
Everolimus is an orally administered inhibitor of the mammalian target of rapamycin (mTOR) recommended for patients with…
Expand
2014
2014
P08.21THE ROLE OF TARGETED THERAPY IN COMPLEX TREATMENT OF PATIENTS WITH BRAIN METASTASES (BM) FROM RENAL CELL CANCER (RCC)
D. Naskhletashvili
,
A. Bekyashev
,
+4 authors
S. Medvedev
2014
Corpus ID: 74825003
BACKGROUND: About 2-11% of all patients (pts) with RCC develop BM, leading to a poor prognosis and a median survival of <6 months…
Expand
2011
2011
YENĠ TANILI ERĠġKĠN AKUT LENFOBLASTĠK LÖSEMĠ HASTALARINDA TOTAL SAĞKALIMI ETKĠLEYEN FAKTÖRLER THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
S. Aksu
,
H. Goker
,
N. Sayınalp
2011
Corpus ID: 76248094
Objective: The prognosis of patients with acute lymphoblastic leukemia (ALL), treated with modern chemotherapeutic regimens, is…
Expand
2011
2011
[Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma].
Xiujuan Chang
,
Yinying Lu
,
+10 authors
Yong-ping Yang
Zhonghua gan zang bing za zhi = Zhonghua…
2011
Corpus ID: 2196025
OBJECTIVES Investigate the clinical efficacy of cryotherapy ablation treatment for advanced hepatocellular carcinoma. analyse the…
Expand
2010
2010
Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.
D. Spigel
,
F. Greco
,
+8 authors
J. Hainsworth
Clinical Lung Cancer
2010
Corpus ID: 5644956
BACKGROUND Targeting epidermal growth factor receptors (EGFRs) has been a novel strategy in treating non-small-cell lung cancer…
Expand
2008
2008
Fractionated stereotactic radiosurgery for primary hepatocellular carcinoma
K. Kang
,
B. Choi
,
+6 authors
I. Choi
2008
Corpus ID: 74270696
15669 Background: Primary hepatocellular carcinoma (HCC) is a poor prognosis tumor. The role of external conventional…
Expand
2006
2006
Evaluación funcional en Cuidados Paliativos : correlación entre diferentes escalas
M. N. Vicuña
,
J. T. Cabello
,
J. P. Sales
,
C. Farré
,
C. Naval
2006
Corpus ID: 70557110
Objetivo: conocer el grado de correlacion entre cuatro escalas de evaluacion funcional (indice de Karnofsky, indice del Eastern…
Expand
2004
2004
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil
A. Mori
,
S. Bertoglio
,
+5 authors
A. Sobrero
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 19112592
We have recently demonstrated that continuous-infusion (CI) 5-fluororacil (FU) eradicates human colon carcinoma cells made…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE